NeuroOne Medical Technologies Corporation Overview
Pro stress-test →NeuroOne Medical Technologies is a medical technology company providing solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, as well as spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients with epilepsy, trigeminal neuralgia, Parkinson's disease, dystonia, essential tremors, and chronic pain. The company's next-generation electrode portfolio leverages flexible thin-film technology, positioning it to address significant clinical needs in neurological diagnosis and treatment.
Strategic Profile
Pro stress-test →NeuroOne is a developmental stage company committed to providing minimally invasive and hi-definition solutions for EEG recording, brain stimulation and ablation solutions. Q2 FY2026 saw 72% YoY product revenue growth to $2.4M, driven by OneRF Brain Ablation sales and strong clinical adoption, with FY2026 guidance of $10.5M and international expansion and drug delivery commercialization targeted for late 2026.
Competitive Landscape
Pro stress-test →NeuroOne develops thin film electrode technology crucial for diagnosing neurological disorders such as epilepsy, Parkinson's disease, dystonia, and essential tremors. The company competes in the neuromodulation and neurosurgery device markets against established players offering deep brain stimulation, ablation, and diagnostic monitoring solutions. NeuroOne's differentiation lies in minimally invasive thin-film electrode technology, though it faces competition from larger medical device manufacturers with established market presence and distribution networks.
Industry Context
NeuroOne Medical Technologies Corporation operates in Neuromodulation and neurosurgical devices.
Key facts
Founded: N/A · Headquarters: Eden Prairie, Minnesota, US · Employees: N/A · Revenue: $12.1M (FY2025) · Market cap: $27.8M